Fructose 1-phosphate

Fructose 1-phosphate (F1P) is a key phosphorylated intermediate in the fructose metabolic pathway that primarily functions as a metabolic signaling molecule to cross-regulate glucose disposal and enterocyte survival. It is generated primarily in the liver, small intestine, and kidneys via the action of ketohexokinase (fructokinase). [1, 2]

• Allosteric Activator of Glucokinase: F1P functions as a critical switch for hepatic glucose uptake. It directly binds to Glucokinase Regulatory Protein (GKRP), prompting GKRP to release glucokinase. Once released, glucokinase translocates from the nucleus to the cytoplasm to rapidly phosphorylate glucose, driving glycogen storage and glycolysis. [1, 2, 3, 4, 5]
• Substrate for Aldolase B: In the specialized fructose-utilization pathway (fructolysis), F1P serves as the central substrate. It is cleaved by aldolase B into dihydroxyacetone phosphate (DHAP) and D-glyceraldehyde. These three-carbon pieces bypass the major regulatory checkpoint of glycolysis (phosphofructokinase-1), allowing rapid conversion into energy or fats. [1, 2, 3, 4, 5]
• Intestinal Villus Elongation: Within intestinal epithelial cells, accumulated F1P acts as a signaling factor that binds to and inhibits the M2 isoform of pyruvate kinase (PKM2). This inhibition triggers a cascade involving hypoxia-inducible factor 1-alpha (HIF-1α), which extends the lifespan of enterocytes, elongates intestinal villi, and enhances nutrient absorption capacities. [1, 2]
• Enzyme Regulation & Carcinogenesis Suppressor: Emerging research highlights its role in specific cell environments, such as its ability to inhibit mannose phosphate isomerase (MPI). In certain contexts like hepatocellular carcinoma, this specific inhibition acts as a metabolic block that helps suppress cancer growth. [1, 2]